Correlation Between Scpharmaceuticals and Vyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Vyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Vyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Vyne Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Vyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Vyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Vyne Therapeutics.

Diversification Opportunities for Scpharmaceuticals and Vyne Therapeutics

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Scpharmaceuticals and Vyne is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Vyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vyne Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Vyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vyne Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Vyne Therapeutics go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and Vyne Therapeutics

Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Vyne Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.77 times less risky than Vyne Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Vyne Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  374.00  in Vyne Therapeutics on August 30, 2024 and sell it today you would lose (79.00) from holding Vyne Therapeutics or give up 21.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Scpharmaceuticals  vs.  Vyne Therapeutics

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Vyne Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Scpharmaceuticals and Vyne Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and Vyne Therapeutics

The main advantage of trading using opposite Scpharmaceuticals and Vyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Vyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vyne Therapeutics will offset losses from the drop in Vyne Therapeutics' long position.
The idea behind Scpharmaceuticals and Vyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years